25OHD₃ does not induce vascular calcification in CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

25OHD₃ restores calcium and PTH levels in CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

The effect of 25OHD3 on the expression of renal PMCA1b and NCX1 in CYP27B1^+/+ and CYP27B1^-/- mice. by Noelia Torremadé (3687523)

25OHD₃ increases expression of CalbindinD-28K in the kidneys of CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

Preserved NSS at 2 and at 24 hours following ischemia and decreased infarct volume in PAR1 KO mice 24 hours following ischemic stroke. by Efrat Shavit-Stein (3186678)

“…(C) Total infarct volume is significantly lower in PAR1 KO mice compared to control (t-test, WT = 6, PAR1 KO = 6). (D) Infarct volume decreases as a function of distance from the ischemic core (slices #5&6). …”

ABCC3 overexpression decreases the retention of anti-cancer agents. by Sai A. Balaji (1452556)

Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

“…In panels A-D, data are expressed as mean percent of control ± s.d and were analyzed by Student’s <i>t</i>-test. …”

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

RL2 decreases viability and induces apoptosis in cultured cells. by Olga A. Koval (548122)

Mean platelet volume and neutrophil to lymphocyte ratio decrease in patients with depression with antidepressant treatment by AHMET ÖZTÜRK (8077292)

“…Methods Forty-nine patients diagnosed with major depressive disorder (MDD) and hospitalized in a university hospital psychiatry inpatient unit retrospectively included in the study. …”

dTTP excess causes a decrease of <i>in organello</i> mtDNA synthesis associated with secondary dCTP depletion. by Emiliano González-Vioque (225780)

“…All results (except panel E) were obtained after 2 hours of <i>in organello</i> reaction. Bars represent mean±SD. A. Effect of an excess of each dNTP on mtDNA replication. …”

Triclabendazole decreases intracellular cAMP. by Yong Joo Lee (357685)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Decreasing infection with heterogeneity in host protection. by M. Gabriela M. Gomes (251416)

βL decreases body mass. by Jeong-sook Lee (127654)

MVK activates microglia and decreases phagocytosis. by Ren Y. Sato (16914027)

Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

“…Six microRNAs (miR-155, miR-454, miR-582-5p, let-7f-1*, miR-181d, and miR-500) had >1.2-fold increase in cirrhotic livers and also had significant negative correlation with hepatic CYP3A activity (range of r = -0.44 to -0.52, P <0.05). …”

At lower concentrations, METH decreases LTP. by Jarod Swant (246454)

“…<p>At higher concentrations, METH increases baseline synaptic transmission and decreases LTP. (<b>A</b>) Summary plot of normalized fEPSP slope measurements recorded in the CA1 region of the hippocampus. …”

Rdh10a deficient embryos have decreased expression of RA signaling responsive genes. by Enrico D’Aniello (798447)

“…<p>(A-F) ISH for <i>cyp26a1</i>, <i>hoxb5b</i>, <i>and dhrs3a</i> expression in control sibling and Rdh10a deficient embryos. …”

CDA-2 decreases pulmonary inflammation. by Xuan Wang (55634)